LRT-1 Cavite Extension: Everything You Need to Know outoftownblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outoftownblog.com Daily Mail and Mail on Sunday newspapers.
Data at week 48 demonstrated that treatment with pegozafermin led to sustained statistically significant improvements across liver fat and non-invasive tests of liver injury/inflammation and.
89bio Inc (NASDAQ: ETNB) released topline data from the blinded extension phase of its Phase 2b ENLIVEN trial evaluating treatment with pegozafermin in patients with